Linda Peckel

Paul G. Mathew, MD and Steven D. Bender, DDS, uniquely encounter patients with TMD and migraine in their respective practice and offer their insight regarding the diagnosis and management this often overlooked comorbidity.

Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV.

Burnout is thought to be the direct result of occupational demands that consistently outweigh the physical, mental, and psychological abilities of individuals suffering from it.

New evidence increasingly points to migraine with aura as a separate entity from migraine without aura.

The potential for metabolic etiologies for migraine opens a whole new approach to treatment, particularly the opportunity to intervene much earlier in the process.

More research is needed to identify the best cost-effective measures for migraine management in underserved and vulnerable people who are uninsured or underinsured.

Researchers suggest that patient dissatisfaction because of adverse effects affects quitting seeking treatment for migraines, among other factors.

Researchers posit that adult studies on headache can help to create a multidisciplinary treatment plan.

Researchers found data that showed the influence of adverse effects on treatment of migraine with antiepileptic medications.

Researchers find that adults who had headaches as children, cognitive and psychomotor ability are compromised. Metacognitive skills, anxiety, depression, motivation, academic performance, human social interactions, and stress symptoms are common headache triggers that may be controlled and monitored by patients.

Researchers found that radiofrequency ablation is a safe and effective therapeutic modality for treatment of resistant headaches associated with pericranial neuralgias; patients also reported less dizziness and insomnia.

Research study results showed that treatments for multiple sclerosis precipitated headaches and migraines.

Researchers found that intranasal lidocaine is effective in the treatment of acute migraine and cluster headache because of its ability to block the sphenopalatine ganglion, which is associated with facial pain from the trigeminal nerve.

Approximately, 26% of participants who were underinsured or uninsured were able to navigate through consultation, diagnosis, and treatment.

In an effort to effectively address global health concerns, the WHO has announced the 13th General Programme of Work, a 5-year strategic plan spanning from 2019 to 2023.

Because of the relative rarity of stroke in children, many clinicians tend to presume that mimics are the cause of the symptoms.

Pharmacologic interventions including oral and injected drugs are a mainstay of spasticity management; however, drug therapies alone are not considered sufficient, and the general consensus supports a broader therapeutic strategy.

The main objection among clinical researchers is that commercially developed products often lack a scientific basis for their selection of features.

In the past, many epilepsy providers have focused solely on seizure control as a way to improve developmental outcomes and HRQOL; however, we now know that the most effective treatment for pediatric epilepsy is comprehensive.

Rosalind C. Kalb, PhD, a clinical psychologist, offers her insights on how clinicians can address patient concerns about reproductive issues and MS.

The comorbid presence of central apnea has been identified by multiple researchers as predictive of SUDEP.

There are many procedural treatments for migraine that are effective and safe, including peripheral nerve blocks, trigger point injections, botulinum toxin injections, and sphenopalatine ganglion blocks.

Neurology Advisor spoke with Jacob Levitt, MD, for his unique medical and patient perspectives on PP.

Pediatric MS is predominantly inflammatory in nature, with a presentation that is similar to a number of other conditions.

Having a higher burden of comorbidities is associated with greater disability progression and lower QoL, as well as increased healthcare utilization and mortality.

The continued observation of this delayed headache syndrome may point to a different pathophysiology from tension-type headache or acute poststroke headache.

Facilities with strict protocols to prevent problems have been able to report significantly lower complication rates.

A rapid increase in the female-to-male ratio of MS incidence has been observed through several population studies.

The main constraint to botulinum toxin use for spasticity is dosage limitation.

Pediatric neurologist Lalitha Sivaswamy, MD, discusses challenges in diagnosing primary intracranial hypertension in pediatric patients.